Who has invested in WestGene Biopharma?

No investors are named on the public record for WestGene Biopharma yet.

WestGene Biopharma Funding: $72M Raised, Series A (2023)

WestGene Biopharma funding overview

WestGene Biopharma is based in Chengdu, China. WestGene Biopharma has raised $72M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in June 2023. The round record for WestGene Biopharma runs through 2023; nothing later has been disclosed.

WestGene Biopharma at a glance

Total raised: $72M
Latest round: Series A
Latest round date: June 2023
Headquarters: Chengdu, China

Frequently asked about WestGene Biopharma funding

How much has WestGene Biopharma raised?: WestGene Biopharma has raised $72M in total disclosed funding across the rounds on record.
Who has invested in WestGene Biopharma?: No investors are named on the public record for WestGene Biopharma yet.
What was the latest WestGene Biopharma funding round?: The most recent disclosed round is a Series A, announced in June 2023.
Where is WestGene Biopharma based?: WestGene Biopharma is based in Chengdu, China.
When did WestGene Biopharma last raise?: The last disclosed WestGene Biopharma round closed in June 2023 at Series A.

WestGene Biopharma totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Chengdu below to benchmark round size and investor mix.

WestGene Biopharma Funding: $72M Raised, Series A (2023)

WestGene Biopharma funding overview

WestGene Biopharma at a glance

Frequently asked about WestGene Biopharma funding

Companies related to WestGene Biopharma (18)

Browse related funding lists (3)